About atDose
atDose is a Healthcare company based in Kawasaki (Japan) founded in 2017 by Hidenori Nakamura. Mobile medication infusion devices are provided by atDose. atDose has raised $1.25 million across 1 funding round. The company has 1 employees. Its chief executive, as recorded, is Hidenori Nakamura. Its focus areas include Traditional Medical Devices. Its legal entity in India is Atdose India Private Limited (U24230KA2022PTC164668).
Company details
atDose was founded in 2017 and is based in Kawasaki, Japan, within the medical devices sector. Mobile infusion devices for medication delivery are developed and supplied by the company to support portable treatment options. Operations emphasize practical healthcare solutions, with leadership directed by Founder and CEO Hidenori Nakamura. Focus remains on enabling patient mobility during therapy.
- Headquarters Kawasaki, Japan
- Employees 1
- Founders Hidenori Nakamura
- SectorsHealthcare
- Website atdose.com
- Social LinkedIn Facebook YouTube
- Legal Name Atdose India Private Limited
- Date of Incorporation 04 Aug, 2022
- Jurisdiction Bangalore, Karnataka, India
- Indian entity net loss-₹3.8 Lakh
FY 2023 · 0% margin
- Indian entity EBITDA-₹3.3 Lakh
FY 2023 · 0% margin
- Total Equity Funding$1.25M (USD)
in 1 rounds
- Employee Count1
Associated legal entities of atDose
atDose operates through Atdose India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Atdose India Private Limited CIN U24230KA2022PTC164668 | Active | 04 Aug 2022 | Bangalore, Karnataka | 4 | View details |
Apps and channels of atDose
its YouTube channel atDose Co., Ltd. has 30 subscribers and 9 videos.
Videos from atDose
The most watched videos on atDose's YouTube channel, atDose Co., Ltd. (30 subscribers). Click a video to play it here.
More on atDose Co., Ltd..
Funding Insights of atDose
atDose has successfully raised a total of $1.25M through 1 strategic funding round. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.25M
- Total Rounds 1
All 1 funding rounds of atDose with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2024 | $1.25M | Series A | โ | โ | DEFTA Partners |
Board of directors of Atdose India Private Limited (atDose)
Atdose India Private Limited is the primary company behind atDose. The board of Atdose India Private Limited currently have 4 directors; the longest-serving is Gopalkrishna Prabhakar Pai, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gopalkrishna Prabhakar Pai DIN 02011857 | Director | 04 Aug 2022 | 4 yrs 2 mo | Atdose India Private Limited |
| Abhijit Vilas Deshpande DIN 09695814 | Director | 04 Aug 2022 | 4 yrs 2 mo | Atdose India Private Limited |
| Hidenori Nakamura DIN 09695815 | Director | 04 Aug 2022 | 4 yrs 2 mo | Atdose India Private Limited |
| Abhishek Choudhury DIN 03296876 | Additional Director | 27 Jan 2026 | 9 mo | Atdose India Private Limited |
People of atDose
1 people are tracked at atDose (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for atDose
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of atDose
Figures of Atdose India Private Limited, the primary company behind atDose, for FY 2023. Net loss was -₹3.8 Lakh (0% margin). EBITDA was -₹3.3 Lakh (0% margin).
- -₹3.8 LakhNet loss · 0% margin
- -₹3.3 LakhEBITDA · 0% margin
- ₹30 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Atdose India Private Limited are on its company page.
Detailed financial statements for atDose
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of atDose
2 dated milestones of atDose across 7 years, from founding to its latest funding, stage changes and deals.
- Founded atDose is founded.
- Funding First funding round.
Web traffic of atDose
The website of atDose (atdose.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 2.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track โ from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about atDose
atDose was founded in 2017 and raised its 1st funding round 7 years after it was founded.
atDose is headquartered in Kawasaki, Japan. It is registered at Kawasaki, Kanagawa, Japan.
Hidenori Nakamura is the CEO of atDose, as recorded in our data. They have also founded this company.
atDose is a funded company, having raised a total of $1.25M across 1 funding round to date. The company's 1st funding round was a Series A of $1.25M, raised on Dec 2024.
atDose has 1 employees.
atDose was founded in 2017 and is based in Kawasaki, Japan, within the medical devices sector. Mobile infusion devices for medication delivery are developed and supplied by the company to support portable treatment options. Operations emphasize practical healthcare solutions, with leadership directed by Founder and CEO Hidenori Nakamura. Focus remains on enabling patient mobility during therapy.
atDose operates through Atdose India Private Limited.
The legal entities of atDose currently have 4 directors, including Gopalkrishna Prabhakar Pai, Abhijit Vilas Deshpande, Hidenori Nakamura and others.